ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV, trading under the ticker ARYD, is a blank-check company sponsored by ARYA Sciences, the life sciences-focused SPAC vehicle affiliated with Perceptive Advisors, a prominent healthcare investment firm. The company completed its initial public offering in 2021 and targets acquisition opportunities in the biopharmaceutical and life sciences sector, consistent with the broader ARYA Sciences franchise strategy. ARYD filed an 8-K with the SEC on June 25, 2024, under accession number 0001140361-24-031248, reflecting continued regulatory activity as the vehicle navigates its deal timeline. Visit SpacDesk and sign up for full access to ARYD's filing history, sponsor profiles, and real-time deal tracking.